Harbour BioMed (2142.HK,HBMHF), a biopharmaceutical company, on Thursday announced the appointment of Adam Zong as its new President.
Zong brings more than 20 years of global biopharma leadership experience.
Zong joins from Arc Nouvel Clinical Development Consulting where he served as Principal Consultant
On the Hongkong Stock Exchange, shares of Harbour closed Thursday's regular trading 2.14 percent higher at HK$14.790
For comments and feedback contact: editorial@rttnews.com
Business News
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.